Grant: Operating Grant - PA: IMHA - New Investigator - Skin Health Bridge Funding
McMaster University
$100,000.00
Proof of concept study of combined topical growth factor and protease inhibitor in chronic wound healing
EF 2014-15
Résumé
Leg ulcers due to venous disease are chronic wounds that can take 6 or more months to heal. Growth factors have been used to try and improve this healing, however, many such studies have failed, and that is thought to be due enzymes in the wound that degrade the growth factors and prevent them from working. This is a proof of concept study that will evaluate the treatment of chronic leg ulcers with topically applied growth factors that are combined with a therapy to prevent their inactivation in the wound.
This combined therapy has the potential to speed up the healing of these wounds and thereby improve the quality of life of patients and reduce the costs to the health system.
Programme
Operating Grant - PA: IMHA - New Investigator - Skin Health Bridge Funding
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
329770
Name
Stacey Michael C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Clinical Investigation - B: Arthritis, Bone, Skin and Cartilage
Projecttitle
Proof of concept study of combined topical growth factor and protease inhibitor in chronic wound healing
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: IMHA - New Investigator - Skin Health Bridge Funding
Keyworddelim
Clinical Trial; Growth Factors; Protease Inhibitors; Venous Ulcers; Wound Healing
Abstract
Leg ulcers due to venous disease are chronic wounds that can take 6 or more months to heal. Growth factors have been used to try and improve this healing, however, many such studies have failed, and that is thought to be due enzymes in the wound that degrade the growth factors and prevent them from working. This is a proof of concept study that will evaluate the treatment of chronic leg ulcers with topically applied growth factors that are combined with a therapy to prevent their inactivation in the wound.
This combined therapy has the potential to speed up the healing of these wounds and thereby improve the quality of life of patients and reduce the costs to the health system.
Competitiondate
201503
Approvedterm2
1 yr 0 mth
Pinamesdelim
Stacey, Michael C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~